About Technology Issues FAQ

Links

Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial

Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.